Get started
Author

Emily R Hennes

Observed names: E. Hennes, Emily Hennes
ORCID: 0000-0001-5882-2515
Observed ORCID: 0000-0001-5882-2515
OpenAlex ID: A5045986706
PARP-inhibitor potpourri: A comparative review of class safety, efficacy, and cost
2020 · Emily R Hennes, Elizabeth N Dow-Hillgartner, et al. · Journal of Oncology Pharmacy Practice · 31
Adapting investigational drug services during a pandemic: Recommendations for future preparedness from the Hematology/Oncology Pharmacy Association Investigational Drug Services Special Interest Group
2022 · Heidi D Finnes, Berrie Child, et al. · American Journal of Health-System Pharmacy · 24
Molecular Genetic Analysis of Bilateral Ovarian Germ Cell Tumors
2012 · E. Hennes, S. Zahn, et al. · Klinische Pädiatrie · 20
Implementation of a chemotherapy stewardship process
2020 · Emily R Hennes, Michael Reed, et al. · American Journal of Health-System Pharmacy · 2
Flat-dose granulocyte colony-stimulating factor evaluation after autologous hematopoietic stem cell transplant in multiple myeloma patients: Does one dose fit all?
2020 · Olivia M Kim, Jason R Jared, et al. · Journal of Oncology Pharmacy Practice
Works count: 5
Citation count: 77
H-index: 3
I10-index: 3
Year
Topic
Type